You are here

Health

Nasal spray for depression gets new approved use

FDA approves Spravato (esketamine) to treat major depressive disorder

This column provided by ONU HealthWise Pharmacy.
Spravato (esketamine) is considered the first big advancement in depression treatment since the approval of Prozac — and it just got approved for a new use.

Approved for treatment-resistant depression (TRD) in March of 2019, esketamine is now approved to treat depressive symptoms in adults with major depressive disorder (MDD) and acute suicidal ideation or behavior.

New COVID-19 test gets green light

FDA approves first COVID-19 test for those without symptoms

This column is provided by the ONU HealthWise Pharmacy.

The US Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for a new COVID-19 diagnostic test that can test people who are not showing symptoms.

This test is found under the name LabCorp COVID-19 RT-PCR.

This test was originally given an EUA in early March. It was to test those whose health care providers suspected that they might have COVID-19, and it only tested individual specimens (no sample pooling). But that changed with this new EUA from the FDA.

Now, this diagnostic option can be used for two new things:

Ask Me Anything about covid-19

Ross Kauffman answers "Are confirmed cases inflated due to repeated tests of the same positive individual?"

This is the first in a series of brief YouTube videos focusing on covid-19. This video is part of Ada SAFE 2020 AMA (ask me anything) question series.

Ross Kauffman, assistant professor and director of public health at Ohio Northern University, speaks to the question: "Are confirmed cases inflated due to the repeated tests of the same positive individual?"

Click here to learn more about this series and to visit the online site that provides resources about the virus.
 

COVID-19 and flu test combined

FDA approves test that can detect both COVID-19 and flu

This column is provided by ONU HeathWise Pharmacy.
 The US Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for a third combination test for COVID-19 and the flu.

This new test is found under the name Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay.

The FDA previously issued EUAs to BioFire Diagnostics LLC and QIAGEN GmbH for their combination tests. These particular combination tests can help identify other respiratory organisms in addition to the viruses that cause the flu and COVID-19.

Dietary supplements for COVID-19? Not so fast

Dietary supplements are not proven to combat COVID-19, new review says

This column is provided by ONU HealthWise Pharmacy. Despite what many celebrities and other unproven sources may say, dietary supplements are not a proven way to combat COVID-19.

That's according to a new review that looked at claims surrounding dietary supplements and COVID-19.

The authors of the article also pointed out that pharmacists can play an essential role in fighting potentially harmful misinformation about the coronavirus.

Covid-19 treatment update

Everything you need to know about the available Covid-19 treatments

This column is provided by Ohio Northern University HealthWise Pharmacy.
As coronavirus cases continue to increase, the search for an effective treatment also continues.

Many potential COVID-19 medications have made the news over the last several months. Recently, for example, remdesivir was granted Emergency Use Authorization (EUA) for the treatment of hospitalized COVID-19 patients with severe illness.

However, the data for remdesivir is mixed. And not all hospitals can get this medication.

Pages